92 filings
8-K
MRSN
Mersana Therapeutics Inc
28 Feb 24
Entry into a Material Definitive Agreement
4:08pm
8-K
MRSN
Mersana Therapeutics Inc
28 Feb 24
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
7:07am
8-K
MRSN
Mersana Therapeutics Inc
5 Jan 24
Regulation FD Disclosure
8:06am
8-K
MRSN
Mersana Therapeutics Inc
21 Dec 23
Termination of a Material Definitive Agreement
4:11pm
8-K
MRSN
Mersana Therapeutics Inc
7 Nov 23
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
7:18am
8-K
d5y1hk 7y66rhjtjq
31 Oct 23
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
8:12am
8-K
bvjkem i9
12 Sep 23
Regulation FD Disclosure
8:27am
8-K
nivpyjyasj51z
6 Sep 23
Departure of Directors or Certain Officers
7:08am
8-K
oqny190whdt 70g
8 Aug 23
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
8:04am
8-K
5jbaydl5wwfjvxw3q9i1
27 Jul 23
Results of Operations and Financial Condition
7:32am
8-K
am44na7l
15 Jun 23
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
7:38am
8-K
7t1iel37oz
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:25pm
8-K
gb1verr89i
9 May 23
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
7:11am
8-K
1w7pffw2txt7oh0d7n
31 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
x7iric
24 Mar 23
Entry into a Material Definitive Agreement
4:12pm
8-K
yhimpd6kajd 58p7
13 Mar 23
Mersana Therapeutics Provides Statement About SVB
8:01am
8-K
ujhll 7dwc4z7vabl8c
28 Feb 23
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Results
7:17am
8-K
id4uztmv2eb7qt2
1 Feb 23
Company plans to report interim data for the combination of UpRi with carboplatin in the second half of 2023
8:18am
8-K
r0gzki8e
25 Jan 23
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors
8:24am
8-K
swh e9f6p
6 Jan 23
Mersana Therapeutics Provides Business Update and Announces Strategic Objectives and Expected Milestones
7:18am